IntelliHep Company

Alzheimer and cancer .IntelliHep is exploiting novel technologies and intellectual property to deliver new heparin-based glycans as novel drug leads for specific diseases including Alzheimer’s disease and cancer. This is being achieved through in-house R&D and the development of strategic collaborative alliances with external partners.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: Undisclosed
Employees Number: 1-10
Funding Status: N/A
Investors Number: 1
Last Funding Type: Non-equity Assistance

Visit Website
Register and Claim Ownership